BR9302910A - Vacina anti-rabica avirulenta - Google Patents

Vacina anti-rabica avirulenta

Info

Publication number
BR9302910A
BR9302910A BR939302910A BR9302910A BR9302910A BR 9302910 A BR9302910 A BR 9302910A BR 939302910 A BR939302910 A BR 939302910A BR 9302910 A BR9302910 A BR 9302910A BR 9302910 A BR9302910 A BR 9302910A
Authority
BR
Brazil
Prior art keywords
avirulent
vaccine
rabic
rabies
glyoprotein
Prior art date
Application number
BR939302910A
Other languages
English (en)
Inventor
Jacqueline Benejean
Anne Flamand
Marie-Christine Tuffereau
Patrice Coulun
Florence Lafay
Original Assignee
Virbac
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virbac filed Critical Virbac
Publication of BR9302910A publication Critical patent/BR9302910A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
BR939302910A 1992-07-20 1993-07-19 Vacina anti-rabica avirulenta BR9302910A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9208947A FR2693655B1 (fr) 1992-07-20 1992-07-20 Vaccin antirabique avirulent.

Publications (1)

Publication Number Publication Date
BR9302910A true BR9302910A (pt) 1994-02-16

Family

ID=9432070

Family Applications (1)

Application Number Title Priority Date Filing Date
BR939302910A BR9302910A (pt) 1992-07-20 1993-07-19 Vacina anti-rabica avirulenta

Country Status (20)

Country Link
US (1) US5853735A (pt)
EP (1) EP0583998B1 (pt)
AT (1) ATE175877T1 (pt)
BG (1) BG61066B1 (pt)
BR (1) BR9302910A (pt)
CA (1) CA2100591C (pt)
CZ (1) CZ283400B6 (pt)
DE (1) DE69323130T2 (pt)
FI (1) FI933210A7 (pt)
FR (1) FR2693655B1 (pt)
HR (1) HRP931065B1 (pt)
HU (1) HU219266B (pt)
MA (1) MA22938A1 (pt)
MX (1) MX9304349A (pt)
PL (1) PL172853B1 (pt)
RO (1) RO112582B1 (pt)
RU (1) RU2128519C1 (pt)
SI (1) SI9300392A (pt)
SK (1) SK280104B6 (pt)
TN (1) TNSN93083A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9915703B1 (pt) * 1998-11-27 2012-09-04 mutante do vìrus da raiva recombinante, e, vacina anti-rábica atenuada viva.
IL146732A0 (en) 1999-06-03 2002-07-25 Nippon Suisan Kaisha Ltd Tricyclic fused heterocycle compounds, process for preparing the same and use thereof
US7074413B2 (en) 2000-03-23 2006-07-11 Thomas Jefferson University Genetically engineered rabies recombinant vaccine for immunization of stray dogs and wildlife
KR20040029377A (ko) * 2001-07-20 2004-04-06 더 유니버시티 오브 죠지아 리서치 파운데이션, 인코포레이티드 공수병의 예방 접종 및 중추신경계 질환의 유전자 요법을위한 인산화 부위의 핵단백질 돌연변이를 갖는 약독화공수병 바이러스
ATE307606T1 (de) 2001-10-04 2005-11-15 Ct Voor Onderzoek In Diergenee Abgeschwächter mutantenstamm eines virus der newcastle-krankheit für eine in ovo impfung und dessen benutzung
DE60231821D1 (de) * 2001-10-10 2009-05-14 Univ Jefferson Rekombinante tollwut-vakzine und verfahren zu ihrer herstellung und verwendung
EP1415665A3 (en) * 2002-11-01 2004-06-30 ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. BHV5 mutants
RS51371B (sr) 2004-07-12 2011-02-28 Thomas Jefferson University, Office Of Technology Transfer Smeše rekombinantnog rabijes virusa
CN101287838B (zh) 2005-10-14 2016-03-30 美国政府健康及人类服务部，疾病控制和预防中心 狂犬病病毒组合物和方法
FR2944292B1 (fr) 2009-04-08 2013-08-23 Sanofi Pasteur Procede de purification du virus rabique
RU2694836C1 (ru) * 2018-12-14 2019-07-17 федеральное государственное бюджетное научное учреждение "Федеральный центр токсикологической, радиационной и биологической безопасности" (ФГБНУ "ФЦТРБ-ВНИВИ") Способ получения антигена вируса бешенства для серологической диагностики

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2580176B1 (fr) * 1985-04-12 1988-02-26 Centre Nat Rech Scient Vaccin antirabique avirulent
DE3526809A1 (de) * 1985-07-26 1987-04-02 Behringwerke Ag Tollwut-lebendimpfstoff
FR2633832B1 (fr) * 1988-07-05 1991-05-31 Virbac Vaccin antirabique avirulent

Also Published As

Publication number Publication date
MA22938A1 (fr) 1994-04-01
FR2693655A1 (fr) 1994-01-21
CZ283400B6 (cs) 1998-04-15
FR2693655B1 (fr) 1994-10-14
RU2128519C1 (ru) 1999-04-10
BG97964A (bg) 1994-04-29
CA2100591A1 (en) 1994-01-21
CZ140293A3 (en) 1994-02-16
HU9302091D0 (en) 1993-11-29
FI933210L (fi) 1994-01-21
TNSN93083A1 (fr) 1994-03-17
MX9304349A (es) 1994-06-30
US5853735A (en) 1998-12-29
PL299739A1 (en) 1994-01-24
BG61066B1 (bg) 1996-10-31
PL172853B1 (pl) 1997-12-31
DE69323130D1 (de) 1999-03-04
DE69323130T2 (de) 1999-06-17
EP0583998B1 (fr) 1999-01-20
HRP931065A2 (en) 1995-02-28
SK280104B6 (sk) 1999-08-06
HU219266B (en) 2001-03-28
FI933210A7 (fi) 1994-01-21
CA2100591C (en) 2003-02-18
HRP931065B1 (en) 1999-12-31
RO112582B1 (ro) 1997-11-28
EP0583998A1 (fr) 1994-02-23
SI9300392A (en) 1994-06-30
HUT69961A (en) 1995-09-28
FI933210A0 (fi) 1993-07-14
SK76193A3 (en) 1994-06-08
ATE175877T1 (de) 1999-02-15

Similar Documents

Publication Publication Date Title
ES2074950A1 (es) Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda.
LU91594I2 (fr) Combinaison d'anatoxine diphtérique, d'anatoxine tétanique, d'anatoxine coquelucheuse, d'hémagglutinine filamenteuse, de pertactine et de virus poliomyélitique inactivé type 1, type 2 et type 3 (Infanrix - IPV)
DE69323130D1 (de) Avirulenter Tollwut-Impfstoff
KR970009347B1 (en) Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3
ATE183241T1 (de) Impstoff gegen streptococcus suis-infektion
DK0425082T3 (da) Vacciner
RU93048174A (ru) Авирулентная вакцина против бешенства и способ ее получения
NL300336I2 (nl) Vaccin tegen de bof dat een jeryl-lynn virusstam bevat
ATE223492T1 (de) Mutanten des infektiösen rinder rhinotracheitis- virus und impfstoffe
FR2633832B1 (fr) Vaccin antirabique avirulent
DK0721782T3 (da) Influenzavaccine indeholdende pertussistoksin
YU50393A (sh) Nova vakcina protiv besnila
FR2580176B1 (fr) Vaccin antirabique avirulent

Legal Events

Date Code Title Description
EE Request for examination
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
FC Decision: refusal
HIFC Refusal cancelled